V. Craig Jordan, OBE, PhD, DSc, FMedSci, of The University of Texas MD Anderson Cancer Center, has been selected by the German Society of Gynecology and Obstetrics as one of “Big Four for the Millennium.” This honor identifies those individuals whose work in the 20th century contributed to women’s health care in the 21st century. Dr. Jordan is recognized as the “father of tamoxifen,” creating the translational research strategies of long-term adjuvant therapy and chemoprevention.

The International Association of HealthCare Professionals is pleased to welcome Silvia G. Corral, MD, to their organization with her upcoming publication in The Leading Physicians of the World. Dr. Corral is a family practitioner, breast cancer survivor, and patient advocate in Santa Barbara, CA.

William T. DeRosa, DO, FACP, has been named Summit Medical Group MD Anderson Cancer Center’s first chief of oncology services. Dr. DeRosa will remain in clinical practice part-time and also will serve on the Summit Medical Group Clinical Council.

ASCO President Daniel F. Hayes, MD, FACP, FASCO, contributed a foreword to a Los Angeles Times supplement discussing the Cancer Moonshot Initiative.

David F. Penson, MD, MPH, of Vanderbilt University Medical Center, is a co-investigator in a research effort that, for the first time in the world, treated a patient in the TULSA-PRO Ablation Clinical Trial (TACT). The trial employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.

Roger Stupp, MD, a leading authority on the treatment of primary and metastatic brain cancer, will join the faculty at Northwestern University Feinberg School of Medicine as a professor of neurosurgery, neurology, and oncology. Dr. Stupp will also be the associate director for strategic initiatives, division chief of neurooncology in the Department of Neurology, and co-director of the Northwestern Brain Tumor Institute at the Robert H. Lurie Comprehensive Cancer Center.

Nicholas J. Sarlis, MD, PhD, joined Sellas Life Sciences Group (New York, NY, and Zug, Switzerland) as chief medical officer, senior vice president, and a member of the executive team.

Benjamin Greer, MD, is retiring from his position of medical director at Seattle Cancer Care Alliance (SCCA), and will be succeeded by Jennie Robertson Crews, MD, MMM, FACP. Dr. Greer was named medical director of the Affiliate Network in 2004 and has been a leader within SCCA and its partner institutions since 1980. Dr. Crews is president of the Association of Community Cancer Centers, and has previously served as the medical director of the Marion L. Shepard Cancer Center in Washington, NC.

Clet Niyikiza, PhD, and his team at L.E.A.F. Pharmaceuticals (“Lifting and Empowering All Families”) won the 2016 Health Care Innovator Award in recognition of their leadership and innovation in the fight against cancer. The award, from the Philadelphia Business Journal, honors people and companies who are disrupting the health care and biotechnology industries and solidifying Greater Philadelphia’s reputation as a center for innovation.

S. Gail Eckhardt, MD, FASCO, has been named the inaugural director of the LIVESTRONG Cancer Institutes of the Dell Medical School at The University of Texas at Austin, as well as associate dean of the medical school.

Betty R. Ferrell, PhD, MA, FAAN, FPCN, was honored as by WedMD as a 2016 Health Hero for her work in palliative care education and advocacy.